UNRESECTABLE SOLID TUMOR
Clinical trials for UNRESECTABLE SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE SOLID TUMOR trials appear
Sign up with your email to follow new studies for UNRESECTABLE SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis phase 1 trial tests a new therapy called MSK-TCR5 for people with advanced solid tumors that have a specific genetic change (RAS G12D mutation) and a certain immune type (HLA-A*11:01). The therapy uses a patient's own T-cells, modified in a lab to better recognize and attack…
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill targets Hard-to-Treat cancers with PIK3CA mutation
Disease control Recruiting nowThis early-phase trial is testing an experimental oral drug called RGT-490 in about 63 adults with advanced solid tumors (including certain breast, ovarian, and endometrial cancers) that have a PIK3CA gene mutation and have stopped responding to standard treatments. The main goal…
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1 • Sponsor: Regor Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug cocktail targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing whether combining two targeted drugs, pemigatinib and afatinib, is safe and can shrink tumors in people with advanced solid cancers that have specific FGTR gene changes. The study includes up to 70 participants whose cancers have spread or cannot…
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests an experimental oral drug called FMC-376 in people with advanced solid tumors (like lung, colorectal, or pancreatic cancer) that have a specific genetic change called KRAS G12C. The trial has three parts: first, finding the safest dose; then, checking how well th…
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Frontier Medicines Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New immune drug targets common cancer mutation in early trial
Disease control Recruiting nowThis early-phase trial is testing a new drug called CLSP-1025 in about 90 adults with advanced solid tumors (like lung, colon, or breast cancer) that have a specific p53 mutation (R175H). The drug works by directing the body's immune cells to attack cancer cells carrying this mut…
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1 • Sponsor: Clasp Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New radioactive nanoparticle targets tough tumors in early trial
Disease control Recruiting nowThis study tests a new radioactive drug called 177Lu-SN201 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to target tumors using tiny particles. The main goals are to check safety, find the right dose, and see if it can s…
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Spago Nanomedical AB • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug targets Hard-to-Treat cancers with PIK3CA mutation
Disease control Recruiting nowThis early-stage study is testing a new drug called RLY-2608, which is designed to block a specific mutant protein (PIK3CA) that helps some cancers grow. The trial includes people with advanced solid tumors or breast cancer that has not responded to other treatments. Participants…
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Proton 'GRID' radiation aims to safely shrink large tumors and ease pain
Symptom relief Recruiting nowThis study tests a new type of radiation called proton GRID for people with large tumors (at least 4.5 cm) that cannot be removed by surgery or have spread. The goal is to safely relieve symptoms like pain. About 24 adults will receive three radiation treatments, and researchers …
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC